UnitedHealth Group Incorporated (NYSE:UNH) Stake Lessened by W.H. Cornerstone Investments Inc.

W.H. Cornerstone Investments Inc. lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 6.4% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,237 shares of the healthcare conglomerate’s stock after selling 85 shares during the period. W.H. Cornerstone Investments Inc.’s holdings in UnitedHealth Group were worth $723,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Vanguard Group Inc. raised its position in shares of UnitedHealth Group by 0.6% during the first quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock worth $41,755,280,000 after purchasing an additional 544,740 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of UnitedHealth Group by 0.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock valued at $12,893,331,000 after acquiring an additional 94,641 shares in the last quarter. Bank of New York Mellon Corp raised its stake in UnitedHealth Group by 0.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock valued at $4,094,247,000 after purchasing an additional 35,533 shares during the period. International Assets Investment Management LLC grew its holdings in shares of UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after buying an additional 5,290,025 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after acquiring an additional 880,183 shares during the period. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on UNH shares. Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Truist Financial reaffirmed a “buy” rating and issued a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Barclays reduced their target price on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their price objective for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. Finally, Stephens cut their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $557.77 on Tuesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The firm has a market cap of $515.06 billion, a PE ratio of 36.34, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63. The business has a fifty day moving average of $581.37 and a 200-day moving average of $542.90.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter last year, the business posted $6.56 earnings per share. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.51%. UnitedHealth Group’s payout ratio is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.